India's food regulator has been tightening its grip on the supplement industry. In July, the Food Safety and Standards Authority of India (FSSAI) prohibited the sale of a folinic acid syrup and another vitamin product over misleading claims and branding. Now, as per the latest development, the regulator has turned its attention to a supplement linked to the booming weight-loss drug market. On October 8, 2026, it issued show-cause notices to Dr. Reddy’s Laboratories, Nestle Health Science, and leading e-commerce platforms, including Amazon India, Flipkart, Netmeds, and contract manufacturer Tirupati Wellness, over allegedly misleading advertising and unapproved health claims for Celevida GLP+, a high-protein supplement marketed for people undergoing GLP-1/GIP weight-loss and diabetes therapies.
\n\nFor Luke Coutinho, Foundational Medicine and Lifestyle Expert, these concerns are not new. In February 2025, he wrote a piece titled 'Wake Up, India: Here’s How We’re Being Fooled About Our Health', questioning whether Indians are wasting money on substandard food and supplements.
\n\nMore recently, he pointed out that influencers have sold magnesium as a fix for sleep, yet many of his patients who take it still cannot sleep well, because the root causes are not addressed and sometimes because the supplement is of poor quality…
Original source: https://www.timesnownews.com/lifestyle
